Related Experiment Video
Updated: Feb 28, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Percutaneous renal sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia
1Derince Education and Research Hospital Department of Cardiology, 41500 Kocaeli, Turkey.
Catheter-based renal sympathetic denervation offers a potential treatment option for patients who have not benefited from standard ablation procedures. This minimally invasive technique targets the renal sympathetic nerves to manage conditions unresponsive to conventional therapies.
Area of Science:
- Interventional Cardiology
- Nephrology
- Hypertension Management
Background:
- Resistant hypertension poses a significant clinical challenge.
- Conventional ablation methods for renal denervation may not always be successful.
Purpose of the Study:
- To evaluate catheter-based renal sympathetic denervation as a therapeutic alternative.
- To assess its efficacy following failed conventional ablation attempts.
Main Methods:
- Utilizing a catheter-based approach to perform renal sympathetic denervation.
- Patient selection included those with prior unsuccessful conventional ablation.
Main Results:
- Catheter-based renal sympathetic denervation demonstrated potential as an alternative treatment.
- Further studies are needed to confirm outcomes in this specific patient group.
Conclusions:
- Renal sympathetic denervation via catheter is a viable option when conventional ablation fails.
- This approach may offer a new avenue for managing complex cases of hypertension.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: β-Blockers
Continuous Renal Replacement Therapy